1 Min Read
April 2 (Reuters) - Novus Therapeutics Inc:
* YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* Q4 LOSS PER SHARE $0.30 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.